Health Care Equipment

AOHUA ENDOSCOPY

AOHUA ENDOSCOPY released FY2026 Q1 earnings on April 29 After-Market (BJT), actual revenue CNY 137.5 M, actual EPS CNY -0.18

AOHUA ENDOSCOPY to Release FY2026 Q1 Earnings on April 30 After-Market BJT

AOHUA ENDOSCOPY to release FY2025 earnings on April 30, during market hours (BJT), with forecast revenue of CNY 775.95 M and EPS of CNY 0.25

AOHUA ENDOSCOPY released FY2025 earnings on February 26 During-Market (BJT), actual revenue CNY 773.87 M (forecast CNY 775.95 M), actual EPS CNY 0.09 (forecast CNY 0.25)

AOHUA ENDOSCOPY released FY2025 Q4 earnings on February 26 During-Market (BJT), actual revenue CNY 351.24 M, actual EPS CNY 0.6236

AOHUA ENDOSCOPY released FY2025 Q3 earnings on October 28 During-Market (BJT), actual revenue CNY 162.28 M, actual EPS CNY -0.1189

AOHUA ENDOSCOPY released FY2025 9 Months earnings on October 28 During-Market (BJT), actual revenue CNY 422.63 M, actual EPS CNY -0.4178

AOHUA ENDOSCOPY to Release FY2025 Q3 Earnings on October 29 During-Market BJT

AOHUA ENDOSCOPY released FY2025 Q2 earnings on August 28 After-Market (BJT), actual revenue CNY 136.62 M, actual EPS CNY -0.0889

AOHUA ENDOSCOPY released FY2025 Semi-Annual earnings on August 28 After-Market (BJT), actual revenue CNY 260.34 M, actual EPS CNY -0.3

AOHUA ENDOSCOPY to Release FY2025 Semi-Annual Earnings on August 29, 2025 (BJT)

Aohua Endoscopy Shareholders Plan to Reduce Holdings

Aohua Endoscopy Shares Up, Brokers Issue Buy Ratings

Aohua Endoscopy's Share Price Dropped After Shareholder Sale

Xiaozhou Optoelectronics Completes 减持 Auhua Endoscopy 0.93% Shares

Aohua Endoscopy Shareholder Reduces Shares

Multiple Securities Firms Recommend Buy Rating for AusLiver

Aihua Endoscopy shareholder Xiaozhou Optoelectronics plans to reduce holdings

Aohua Endoscopy Reveals 2025 Employee Stock Ownership Plan

Aohua Endoscopy Shareholders Reduce Shares by 2.998% of Total Capital

688212

According to the Zhitong Finance APP, AOHUA ENDOSCOPY announced that Mr. Gu Xiaozhou, the company's controlling shareholder, one of the actual controllers, director, and general manager, plans to reduce his holdings by no more than 2.6 million shares through centralized bidding and block trading, with a total reduction ratio not exceeding 1.93% of the company's total share capital

Zhitong

One of the actual controllers of AOHUA ENDOSCOPY, Gu Xiaozhou, plans to reduce his holdings by no more than 1.93%

AOHUA ENDOSCOPY announced that its operating revenue in the first half of 2025 was 260 million yuan, a year-on-year decrease of 26.36%. The net loss attributable to shareholders of the listed company was 40.7652 million yuan, compared to a net profit of 5.6616 million yuan in the same period last year

AOHUA ENDOSCOPY: Net loss of 40.7652 million yuan in the first half of 2025

688580

688273

688626

The medical equipment sector has seen a short-term decline, with MEDLANDER falling over 7%. Xiangyu Medical, AOHUA ENDOSCOPY, Lude Medical, VISHEE, and others have also followed suit

VISHEE

MEDLANDER

Xiangyu Medical

The medical equipment sector has declined in the short term, with MEDLANDER falling over 7%

300633

300760

688271

CITIC Securities released a research report indicating that the scale of medical equipment bidding and procurement will continue to grow in the first half of 2025, benefiting from the implementation of equipment renewal policies, which is expected to drive a long-term increase in medical equipment procurement levels. The industry rating is maintained at "Overweight," recommending companies such as Mindray, United Imaging Healthcare, SONOSCAPE, and AOHUA ENDOSCOPY. The notice issued by four ministries in 2024 aims for a growth of over 25% in equipment investment scale by 2027, which is expected to alleviate the financial pressure on hospitals and promote the recovery of equipment companies' performance

SONOSCAPE

Mindray

United Imaging Healthcare

Cathay Haitong: The medical equipment renewal policy continues to be implemented, and the procurement scale in 25H1 maintains rapid growth

According to the Zhitong Finance APP, AOHUA ENDOSCOPY announced that Junlian Xinkang and Gao Shen plan to reduce their holdings in the company through centralized bidding and block trading, with a total reduction of no more than 2.5818 million shares, accounting for no more than 1.92% of the company's total share capital

AOHUA ENDOSCOPY: Junlian Xinkang and Gao Shan plan to reduce their holdings by a total of no more than 1.92% of the company's shares

According to the Zhitong Finance APP, AOHUA ENDOSCOPY announced that on June 23, 2025, the company received a notice from its shareholders Gu Kang, Gu Xiaozhou, and their controlled entity Xiaozhou Optoelectronics. As of June 23, 2025, Xiaozhou Optoelectronics has cumulatively reduced its holdings in the company by 1.2528 million shares through centralized bidding transactions, accounting for 0.93% of the company's total shares. This reduction plan has been completed

AOHUA ENDOSCOPY: Xiaozhou Optoelectronics has cumulatively reduced its holdings in the company by 0.93%

According to the Zhitong Finance APP, AOHUA ENDOSCOPY announced that the company recently received a notice from Gu Kang, Gu Xiaozhou, and their controlled entity, Xiaozhou Optoelectronics, stating that Xiaozhou Optoelectronics plans to reduce its holdings by a total of no more than 1.2528 million shares through centralized bidding and block trading, which does not exceed 0.93% of the company's total share capital

AOHUA ENDOSCOPY: Xiaozhou Optoelectronics plans to reduce its holdings by no more than 0.93%

AOHUA ENDOSCOPY plans to launch an employee stock ownership plan in 2025, with no more than 22 participants, intending to hold no more than 1,499,300 shares, accounting for 1.11% of the company's total share capital. The planned fundraising cap is 60 million yuan, with each subscription unit priced at 1 yuan, and the repurchase price for shares set at 40.02 yuan/share

AOHUA ENDOSCOPY plans to launch an employee stock ownership plan in 2025

According to the Zhitong Finance APP, AOHUA ENDOSCOPY announced that on May 12, 2025, the company received a notice from its shareholders Junlian Xinkang and Gao Shen. As of the date of this announcement, Junlian Xinkang and Gao Shen have cumulatively reduced their holdings of the company's shares by 4.0375 million shares through centralized bidding and block trading, accounting for 2.998% of the company's current total share capital. The time period for this reduction plan has expired

AOHUA ENDOSCOPY: Junlian Xinkang and Gao Shen have cumulatively reduced their holdings in the company by 4.0375 million shares

On April 27th, AOHUA ENDOSCOPY announced that the company received a value-added tax refund of RMB 4.9524 million for software products on the same day, all of which are government subsidies related to revenue

AOHUA ENDOSCOPY: Received government subsidy of 4.9524 million yuan

AOHUA ENDOSCOPY(688212.SH)